Guru’s November 2016 Rebalance Report

Dec 15, 2016

On November 25th, the Global X Guru suite of ETFs, which track the equity investments of major hedge funds, underwent their quarterly rebalances. This suite includes the Global X Guru Index ETF (GURU), the Global X Guru Activist Index ETF (ACTX), and the Global X Guru International Index ETF (GURI). The November 2016 GURU Report can be found here.

Below is a summary of this report as well as additional information on the performance and trends within the US hedge fund industry.

  • Between the most recent quarterly rebalances (August 24th to November 23rd), all three funds, GURU, ACTX, & GURI, outperformed their benchmarks by an average of 187 bps
  • Low quarterly turnover numbers across the Global X funds indicate perhaps stronger conviction among hedge funds in their major positions, with an average of just 16% turnover in GURU, ACTX, & GURI over the last two rebalances

Quarterly Performance

Performance data current to the most recent month- and quarter-end can be found at the following links: GURU, GURI, ACTX.

High conviction hedge fund picks in the health care sector, particularly in biotech, had been battered over a heightened likelihood of increased regulatory controls on drug prices. Many hedge funds remained confident that the market was mispricing these stocks, and held steady on their biotech holdings. This resolve was ultimately rewarded as GURU’s health care stocks have rallied 18% since GURU’s May rebalance, while the S&P 500’s health care sector has been down -1.4% during this period.1

Among activist hedge funds, we observed overweights in the Energy and Materials sectors as activists identified these companies as ripe for disruption. These bets have paid off handily with ACTX’s Energy and Materials picks up 22% and 17%, respectively, since ACTX’s May rebalance, compared to the S&P 500’s Energy and Materials sectors up only 8% and 5%, respectively.1

On the international side, markets experienced greater ranges of performance dispersion as major Western European markets sold off while commodity exposed Developed and Emerging markets led the way. GURI’s overweight positions to Canada and Brazil, nations with higher than average commodity exposure, proved beneficial, as these positions generated nearly 80% of the fund’s outperformance.1 A stronger global macro backdrop, improving commodities outlook, and constructive monetary policy drove returns in these markets after a prolonged slump.

Looking Forward

While the industry has faced challenges ranging from fee pressures to periods of underperformance, hedge funds still remain uniquely positioned to potentially generate alpha due to their deep talent pool and ability to make high conviction investments. Direct investments into hedge funds, however, often requires paying high fees and entering into lock-up periods that reduce liquidity. We believe that a more liquid, tax-efficient, and cost-effective vehicle like an ETF can be preferable exposure to high conviction hedge fund investments.

Category: Reports

Topics: Other Equities

Investing involves risk, including the possible loss of principal. The 13F filings used to select the securities in the Underlying Index for each fund are filed by each hedge fund approximately 45 days after the end of each calendar quarter. Therefore a given hedge fund may have already sold its position by the time of the 13F filing. For GURU, the fund’s manager has the ability to employ up to 20% leverage, which may accelerate the velocity of potential gains or losses. The funds may invest in small and mid-capitalization companies, which have greater volatility and less financial resources than large-capitalization companies. Furthermore, the funds may hold foreign securities which are subject to different risks than domestic securities, including foreign currency fluctuation, different financial and accounting standards, and political instability. Investments in the securities of foreign issuers (including investments in American Depositary Receipts (“ADRs”)) are subject to the risks associated with investing in those foreign markets, such as heightened risks of inflation or nationalization. The Funds are non-diversified.

Shares of Global X Funds are bought and sold at market price, not NAV, and are not individually redeemed from the fund. Buying and selling shares will result in brokerage commissions.

The Funds are obliged to distribute portfolio gains to shareholders by year-end. These gains may be generated due to index rebalancing or to meet diversification requirements. Trading shares of the Funds will also generate tax consequences and transaction expenses.

This information is not intended to be individual or personalized investment or tax advice. Please consult a financial advisor or tax professional for more information regarding your tax situation. The fund is required to distribute income and capital gains which may be taxable. Buying and selling shares will result in brokerage commissions and tax consequences. Shares are only available through brokerage accounts which may have minimum requirements. Only whole shares may be purchased.

Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds’ summary or full prospectus, which may be obtained by calling 1-888-GX-FUND-1 (1.888.493.8631), or by visiting Read the prospectus carefully before investing.

Global X Management Company, LLC serves as an advisor to the Global X Funds. The Global X Funds are distributed by SEI Investments Distribution Co., One Freedom Valley Drive, Oaks, PA, 19456, which is not affiliated with Global X Management Company or any of its affiliates.